10-1074 - National Institute of Allergy and Infectious Diseases, Rockefeller University, Gilead
3BNC117 - Rockefeller University, Cornell University, Frontier Biotech, Gilead
teropavimab (GS-5423) - Gilead
Selzentry (maraviroc) - ViiV Healthcare
zinlirvimab (GS-2872) - Gilead
Rukobia (fostemsavir extended release) - ViiV Healthcare
https://eacs2025.abstractserver.com/program/#/details/presentations/695
 
H.M. Fritsch 1; C. Houdré 1; A. Moreau 1; V. Andriantsoanirina 2; F. Mammano 1; C. Goujard 2; M.-L. Chaix 3; L. Meyer 2; K. Stefic 4; ANRS PRIMO Cohort Study Group
 
Jul 16, 2025
 
Prev Next